Get the Stockscreener App
6.67
1.06%
0.07
After Hours:
6.80
0.13
+1.95%
Evolent Health Inc stock is traded at $6.67, with a volume of 3.19M.
It is up +1.06% in the last 24 hours and down -21.16% over the past month.
Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The primary solutions provided by the company include specialty care management services, total cost of care management, and administrative services.
See More
Previous Close:
$6.60
Open:
$6.67
24h Volume:
3.19M
Relative Volume:
1.09
Market Cap:
$783.78M
Revenue:
$2.35B
Net Income/Loss:
$-74.42M
P/E Ratio:
-7.0957
EPS:
-0.94
Net Cash Flow:
$150.93M
1W Performance:
-14.60%
1M Performance:
-21.16%
6M Performance:
-32.35%
1Y Performance:
-71.43%
1-Day Range:
$6.525
$6.84
1-Week Range:
$6.525
$7.88
52-Week Range:
$6.525
$25.22
Evolent Health Inc Stock (EVH) Company Profile
Name
Evolent Health Inc
Sector
Industry
Phone
571-389-6000
Address
1812 NORTH MOORE ST, SUITE 1705, ARLINGTON
Compare EVH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
EVH
Evolent Health Inc
|
6.67 | 765.41M | 2.35B | -74.42M | 150.93M | -0.94 |
|
VEEV
Veeva Systems Inc
|
291.20 | 46.72B | 2.97B | 809.93M | 1.33B | 4.8743 |
|
TEM
Tempus Ai Inc
|
89.85 | 14.99B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
66.00 | 12.33B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
94.58 | 8.01B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
35.85 | 7.09B | 906.14M | -52.62M | 89.62M | -0.3621 |
Evolent Health Inc Stock (EVH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-10-25 | Initiated | Needham | Buy |
| Dec-03-24 | Reiterated | BTIG Research | Buy |
| Nov-08-24 | Downgrade | Stephens | Overweight → Equal-Weight |
| Oct-11-24 | Initiated | KeyBanc Capital Markets | Overweight |
| Aug-09-24 | Upgrade | Truist | Hold → Buy |
| Apr-22-24 | Initiated | Citigroup | Buy |
| Mar-01-24 | Initiated | Oppenheimer | Outperform |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Dec-06-23 | Initiated | JMP Securities | Mkt Outperform |
| Oct-16-23 | Initiated | UBS | Buy |
| Apr-12-23 | Initiated | Stephens | Overweight |
| Nov-01-22 | Initiated | Truist | Hold |
| Jul-29-22 | Initiated | RBC Capital Mkts | Outperform |
| Mar-30-22 | Initiated | Guggenheim | Buy |
| Nov-18-21 | Upgrade | JP Morgan | Neutral → Overweight |
| Apr-29-21 | Resumed | JP Morgan | Neutral |
| Jan-07-21 | Initiated | BTIG Research | Buy |
| Jul-06-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Jun-05-20 | Downgrade | Goldman | Buy → Neutral |
| Jun-02-20 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Oct-05-18 | Resumed | Leerink Partners | Outperform |
| Jun-04-18 | Initiated | Piper Jaffray | Overweight |
| Apr-24-18 | Resumed | JP Morgan | Neutral |
| Sep-20-17 | Initiated | KeyBanc Capital Mkts | Overweight |
| Jun-02-17 | Initiated | Robert W. Baird | Outperform |
| Mar-14-17 | Initiated | Oppenheimer | Outperform |
| Jan-13-17 | Upgrade | Wells Fargo | Market Perform → Outperform |
| Oct-28-16 | Resumed | JP Morgan | Overweight |
| Aug-05-16 | Reiterated | FBR Capital | Outperform |
| Jul-26-16 | Initiated | Jefferies | Buy |
| Jul-13-16 | Reiterated | FBR Capital | Outperform |
| Mar-29-16 | Initiated | FBR Capital | Outperform |
| Jan-06-16 | Initiated | Canaccord Genuity | Buy |
| Jun-30-15 | Initiated | Goldman | Buy |
| Jun-30-15 | Initiated | JP Morgan | Overweight |
| Jun-30-15 | Initiated | Leerink Partners | Outperform |
| Jun-30-15 | Initiated | Sun Trust Rbsn Humphrey | Buy |
View All
Evolent Health Inc Stock (EVH) Latest News
What indicators show strength in Evolent Health Inc.Market Movement Recap & AI Driven Price Forecasts - newser.com
Will Evolent Health Inc. (9EH) stock benefit from Fed rate cutsQuarterly Portfolio Review & Breakout Confirmation Trade Signals - newser.com
Why Evolent Health Inc. (9EH) stock is a must watch tickerRisk Management & Safe Entry Zone Identification - newser.com
What MACD signals say about Evolent Health Inc.July 2025 Closing Moves & Momentum Based Trading Signals - newser.com
Is Evolent Health Inc. a candidate for recovery play2025 Dividend Review & Consistent Return Strategy Ideas - newser.com
Evolent Health Stock Plummets to New 52-Week Low of $6.58 - Markets Mojo
Privia Health's Premium: A Breakout Play (PRVA) - Seeking Alpha
How Evolent Health Inc. stock benefits from tech adoptionProfit Target & Fast Gaining Stock Strategy Reports - newser.com
Reversal indicators forming on Evolent Health Inc. stockMarket Volume Report & Smart Money Movement Alerts - newser.com
How Evolent Health Inc. stock reacts to Fed rate cuts2025 Price Momentum & Weekly High Return Forecasts - newser.com
Will Evolent Health Inc Class stock top growth indexesVolume Spike & Weekly Watchlist of Top Performers - newser.com
Published on: 2025-10-31 02:55:23 - newser.com
Is Evolent Health Inc. (9EH) stock a buy for dividend portfoliosWeekly Trend Recap & AI Powered Trade Plan Recommendations - newser.com
Evolent Health Inc. stock prediction for this weekInsider Buying & Technical Confirmation Trade Alerts - newser.com
What high frequency data says about Evolent Health Inc.2025 Buyback Activity & Risk Controlled Stock Alerts - newser.com
Risk vs reward if holding onto Evolent Health Inc.2025 Big Picture & Scalable Portfolio Growth Ideas - newser.com
Applying Wyckoff theory to Evolent Health Inc. stockMarket Rally & Free Community Supported Trade Ideas - newser.com
Insufficient Growth At Evolent Health, Inc. (NYSE:EVH) Hampers Share Price - simplywall.st
Will Evolent Health Inc. stock see insider buyingJuly 2025 Closing Moves & Fast Moving Stock Watchlists - Fundação Cultural do Pará
Peregrine Capital Management LLC Grows Stock Holdings in Evolent Health, Inc $EVH - MarketBeat
Will Evolent Health Inc. stock gain from lower inflation2025 Earnings Surprises & Accurate Buy Signal Notifications - Fundação Cultural do Pará
Is Evolent Health Inc. stock in correction or buying zoneQuarterly Trade Review & Weekly Setup with ROI Potential - Fundação Cultural do Pará
Published on: 2025-10-27 21:52:49 - newser.com
Shorts Report: How Evolent Health Inc. stock benefits from tech adoptionJuly 2025 Update & Safe Investment Capital Preservation Plans - Fundação Cultural do Pará
Setup Watch: Will Evolent Health Inc. stock gain from lower inflation2025 Analyst Calls & Advanced Technical Signal Analysis - Fundação Cultural do Pará
Evolent Health Inc Stock (EVH) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.38%
0.07%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):